Italian Social Tariffs For QALYs Calculation Are Now Available

Published Jun 17, 2013
Milano and Napoli, Italy - The Italian health care system is starting to take information on HRQoL and QALYs into consideration when deciding on the utilization of available resources. Although comparisons of different national value sets have demonstrated the existence of country specificity of utilities, in Italy, a specific value set was still missing.  In the study “Italian Population-Based Values of EQ-5D Health States,” published in Value in Health, researchers from Milan and Napoli created the first Italian general population EQ-5D value set, thus offering the possibility of its use in cost-utility analyses targeted at the Italian health care system. In their study, authors Scalone et.al, estimated the first value set for the calculation of Italian-specific QALYs, based on preferences elicited on EQ-5D health states using the time trade-off technique. They followed the Standard EuroQoL Measurement and Valuation of Health (MVH) protocol revised in 2009, and involved a sample of the Italian general adult population representative of age, gender and geographical distribution. By investigating several regression models, the researchers were able to determine which one provides the most logically consistent estimates and with a good level of statistical efficiency. Lorenzo Mantovani, DSc, Senior Researcher at the Department of Clinical Medicine and Surgery, Federico II University of Naples, says, “With the publication of this study, Italian researchers and policy makers will be able to use QALYs calculated with the standard reference tool EQ-5D, finally, based on Italian-specific social tariffs.” The study was financed by the EuroQol and CHARTA Foundations.

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

Rethinking Medication Adherence: A Stakeholder Blueprint

May 12, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a report from its Medication Adherence and Persistence Special Interest Group that provides valuable insights into the perspectives of key stakeholders on interventions to improve medication adherence. The report, “Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions: An ISPOR Report,” was published in the May 2025 issue of Value in Health.

New Research Reveals Surprising Trends in Women's Health Economics Authorship

May 12, 2025

Value in Health, the official journal of ISPOR announced the publication of new research analyzing women's representation in authorship of papers submitted to and published in Value in Health. The report, “How Well Are Women Represented in Authorship in HEOR? An Analysis of Value in Health: An ISPOR Report,” was published in the May 2025 issue of Value in Health.

Redefining Value in Care for Alzheimer's Disease and Dementia

Apr 8, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that provide crucial insights into the complex health economics of Alzheimer's disease and related dementias (ADRD), offering a roadmap for future research and policy as the aging population grows and novel treatments emerge.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×